Stocks / CLGN
Stock profile · 銘柄

CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)

CLGN did not make Shishin's board on 2026-09-01: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company. The figures below are research data, the mechanical screen result and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Shishin's live daily signals are published each morning on the rankings board.

Shishin Score33
In today's boardNo
SetupOTHER
Last close$0.39
SectorHealthcare-Products
Today's scan · 2026-09-01
Not screenedComposite 33/100

CLGN did not make Shishin's board on 2026-09-01: not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a view on the company.

Position
67
Thrust
29
Breakout
20
Base
60
Volatility
100
Liquidity
30
Indicators · as of 2026-09-01
ADR · 20d22.0%
ATR · 1421.6%
RSI · 1463
Return · 30d+24%
Return · 60d-2%
Above MA2022%
Above MA5017%
Range · 20d264%
MA stack2
From 52w high-88%
$ Vol · 30d$2M
Vol ratio540.12×
Frequently asked

Is CLGN a Shishin signal?

On 2026-09-01, CLGN is not in Shishin's board. Not in a strong uptrend (60-day return under 30%, or below its 50-day average). This is a mechanical screen result, not a recommendation.

What is CLGN's Shishin momentum score?

As of 2026-09-01, CLGN's composite momentum score is 33/100, a weighted blend of momentum, trend, and volatility indicators on a 0 to 100 scale.

Why didn't CLGN make the board?

Not in a strong uptrend (60-day return under 30%, or below its 50-day average). Shishin's board takes only the names that clear its liquidity, trend, and score thresholds for the active market regime.

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →Rate your watchlist →All covered stocks →